Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Care
Cancer treatment
Immunotherapy
Immunooncology
Medical
Solid tumors
Pharmaceutical
Adoptive cell therapy
T cell receptor technologies
Date founded
2016
Funding rounds raised
Z
Zelluna Immunotherapy raised undisclosed on August 25, 2022
Investors: Takeda UK Limited